Sponsor or institution
Clinical trials and research at FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
As of November 12, 2026, Find a Trial lists 7 clinical trials run by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS that are recruiting, at sites in 8 countries (most in Italy (7), Germany (2), Poland (2)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 8Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| ePro Diary for people with HDV (MACROLIVER) | — | Bergamo, Italy | Recruiting | Mar 2, 2026 |
| Active Delta Referral — screening to care pathway | — | Bergamo | Recruiting | Jan 5, 2026 |
| ELN multicenter analysis of phenotypic evolution and clinical outcomes | — | Rochester, Minnesota and 23 other locations | Recruiting | Oct 2, 2025 |
| Investigating the role of clonal hematopoiesis in heart failure | — | Bergamo and 1 other locations | Recruiting | Oct 4, 2024 |
| Observational study on patients with myelofibrosis in Europe | — | Yerevan and 26 other locations | Recruiting | Aug 1, 2024 |
| Observing the effects of ropeginterferon alfa-2b in patients with Polycythemia Vera | — | Bergamo, Lombardy and 36 other locations | Recruiting | Jul 17, 2024 |
| Digital tool for managing liver disease in young patients | — | Bergamo, MILANO | Recruiting | Apr 2, 2024 |
All recruiting trials (7)
-
ePro Diary for people with HDV (MACROLIVER)
This project will try a mobile ePro diary app to help adults with Delta hepatitis (HDV) track symptoms and share health information with their care team.
-
Active Delta Referral — screening to care pathway
This project will try an automatic 'HDV-reflex' screening to find how common hepatitis D is among adults with hepatitis B who are hospitalized or served by addiction and prison health services in Bergamo.
-
ELN multicenter analysis of phenotypic evolution and clinical outcomes
This study tries to find features linked to JAK2V617F-positive essential thrombocythemia (ET) patients who later developed polycythemia vera (PV) by comparing them with matched ET patients who did not progress and with patients diagnosed with de novo PV.
-
Investigating the role of clonal hematopoiesis in heart failure
This study looks at how changes in blood cell production might affect inflammation and heart problems in people with heart failure.
-
Observational study on patients with myelofibrosis in Europe
This study is collecting information from patients with myelofibrosis across Europe to better understand the disease and improve how it's diagnosed and treated.
-
Observing the effects of ropeginterferon alfa-2b in patients with Polycythemia Vera
This study is testing how well the drug ropeginterferon alfa-2b works and is tolerated by people with Polycythemia Vera who need treatment.
-
Digital tool for managing liver disease in young patients
This study is testing a new digital tool to help young people with liver disease manage their care better as they transition from pediatric to adult healthcare.
Quick answers
How many clinical trials run by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in Italy (7 trials), Germany (2 trials), Poland (2 trials), Spain (2 trials), Armenia (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.